Showing results (51-60 of 346) with videos related to
Sort By:
Pageof 35
Human Factors|June 4, 1999
Designing an interface to optimize reading with small display windowsT Rahman, P MuterJournal of Clinical Microbiology|September 1, 1993
Combining pooling and alternative algorithms in seroprevalence studiesJ M Raboud, C Sherlock, M T Schechter, et al.Pediatrics|April 1, 1989
Retinopathy of prematurity: a new epidemic?D L Gibson, S B Sheps, M T Schechter, et al.Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 7, 2003
The impact of needle-exchange programs on the spread of HIV among injection drug users: a simulation studyJ M Raboud, M C Boily, J Rajeswaran, et al.AIDS (London, England)|July 1, 1992
Application of the World Health Organization system for HIV infection in a cohort of homosexual men in developing a prognostically meaningful staging systemJ S Montaner, T N Le, N Le, et al.Canadian Medical Association Journal|June 1, 1985
The Vancouver Lymphadenopathy-AIDS Study: 1. Persistent generalized lymphadenopathyM T Schechter, W J Boyko, E Jeffries, et al.Canadian Medical Association Journal|July 1, 1985
The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathyW J Boyko, M T Schechter, E Jeffries, et al.The British Journal of Dermatology|January 6, 2009
Economic evaluation of systemic therapies for moderate to severe psoriasisS Sizto, N Bansback, S R Feldman, et al.Annals of Internal Medicine|July 1, 1990
Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)J S Montaner, L M Lawson, N Levitt, et al.The Journal of Infectious Diseases|March 1, 1997
Issues in the design of trials of therapies for subjects with human immunodeficiency virus infection that use plasma RNA level as an outcomeJ M Raboud, J S Montaner, S Rae, et al.Pageof 35